申请人:Nissan Chemical Corporation
公开号:EP3939663A1
公开(公告)日:2022-01-19
The present invention relates to a novel means for treating corneal diseases. The present invention provides a therapeutic agent for corneal diseases, containing a compound represented by the following formula (I):
wherein each symbol is as defined in the DESCRIPTION, or a salt thereof.
本发明涉及一种治疗角膜疾病的新型方法。本发明提供了一种角膜疾病治疗剂,其中含有下式(I)所代表的化合物:
其中各符号如描述中定义,或其盐。